Specify a stock or a cryptocurrency in the search bar to get a summary
Eris Lifesciences Limited
ERISEris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India. The company offers various branded formulations in various therapeutic areas, such as anti"diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women's health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and ante-natal care solutions. It offers its products through wholesale drug distributors, and stockiest and retail pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India. Address: Shivarth Ambit, Ahmedabad, India, 380054
Analytics
WallStreet Target Price
127 785.32 INRP/E ratio
51.0254Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ERIS
Dividend Analytics ERIS
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
29 %Dividend History ERIS
Stock Valuation ERIS
Financials ERIS
Results | 2019 | Dynamics |